06-08-2024 |
AH |
|
RIGL |
Rigel Pharmaceuticals, Inc. |
176.11 |
-0.06 |
-0.37 |
-0.40 |
Rigel Pharmaceuticals GAAP EPS of -$0.06 beats by $0.14, revenue of $36.84M beats by $3.14M [8/6/2024 4:37 PM] |
9.92 |
0.59 (6.32%) |
10.40 |
1.07 (11.47%) |
7.12 - 17.30 |
88,597 |
90,000 |
1,671 |
|
|
07-05-2024 |
AH |
|
RIGL |
Rigel Pharmaceuticals |
202.00 |
-0.05 |
-0.03 |
0.00 |
Rigel Pharmaceuticals GAAP EPS of -$0.05 misses by $0.02, revenue of $29.53M misses by $1.94M [5/7/2024 4:32 PM] |
0.9924 |
-0.20 (-16.60%) |
1.10 |
-0.09 (-7.56%) |
0.71 - 1.96 |
3,338,349 |
1,690,000 |
26,226 |
|
|
05-03-2024 |
AH |
|
RIGL |
Rigel Pharmaceuticals |
265.00 |
N/A |
-0.03 |
0.00 |
Rigel Pharmaceuticals GAAP EPS of $0.00 beats by $0.02, revenue of $35.8M beats by $2.39M [3/5/2024 4:08 PM] |
1.56 |
0.08 (5.74%) |
1.51 |
0.03 (2.03%) |
0.71 - 1.96 |
3,305,522 |
1,450,000 |
23,939 |
|
|
07-11-2023 |
AH |
|
RIGL |
Rigel Pharmaceuticals, Inc. |
153.63 |
-0.03 |
-0.06 |
-0.11 |
Rigel Pharmaceuticals GAAP EPS of -$0.03 beats by $0.04, revenue of $28.13M beats by $0.93M [11/7/2023 4:15 PM] |
0.8810 |
0.01 (1.21%) |
0.91 |
0.04 (4.54%) |
0.67 - 2.04 |
484,782 |
550,000 |
10,008 |
|
|
01-08-2023 |
AH |
|
RIGL |
Rigel Pharmaceuticals, Inc. |
230.98 |
-0.04 |
-0.08 |
-0.08 |
Rigel Pharmaceuticals GAAP EPS of -$0.04 beats by $0.04, revenue of $26.89M beats by $1.19M [8/1/2023 4:30 PM] |
1.30 |
-0.03 (-1.88%) |
1.32 |
-0.01 (-0.75%) |
0.67 - 2.04 |
1,291,652 |
1,130,000 |
10,192 |
|
|
02-05-2023 |
AH |
4:00 PM ET (May 2) |
RIGL |
Rigel Pharmaceuticals, Inc. |
194.49 |
-0.08 |
-0.09 |
-0.16 |
Rigel Pharmaceuticals GAAP EPS of -$0.08 beats by $0.02, revenue of $26.07M beats by $2M [5/2/2023 4:32 PM] |
1.16 |
0.02 (1.75%) |
1.18 |
0.04 (3.51%) |
0.64 - 2.71 |
1,677,560 |
1,360,000 |
13,212 |
|
|
07-03-2023 |
AH |
4:00 PM ET (Mar 7) |
RIGL |
Rigel Pharmaceuticals, Inc. |
266.17 |
0.01 |
-0.09 |
-0.13 |
Rigel Pharmaceuticals GAAP EPS of $0.34 beats by $0.80, revenue of $120.24M beats by $27.04M [3/7/2023 4:02 PM] |
1.78 |
0.31 (21.09%) |
1.79 |
0.32 (21.77%) |
0.64 - 3.52 |
20,964,529 |
2,550,000 |
8,699,203 |
|
|
03-11-2022 |
AH |
4:00 PM ET (Nov 3) |
RIGL |
Rigel Pharmaceuticals, Inc. |
130.18 |
-0.11 |
-0.13 |
-0.12 |
Rigel Pharmaceuticals GAAP EPS of -$0.11 beats by $0.03, revenue of $22.4M misses by $0.21M [11/3/2022 4:06 PM] |
0.7439 |
0.02 (2.54%) |
0.72 |
0.0 (-0.21%) |
0.64 - 3.52 |
837,499 |
1,650,000 |
13,580 |
|
|
02-08-2022 |
AH |
4:00 PM ET (Aug 2) |
RIGL |
Rigel Pharmaceuticals, Inc. |
196.14 |
-0.08 |
-0.12 |
-0.08 |
Rigel Pharmaceuticals GAAP EPS of -$0.08 beats by $0.04, revenue of $29.82M beats by $6.17M [8/2/2022 4:19 PM] |
1.39 |
0.09 (6.92%) |
1.57 |
0.27 (20.77%) |
0.64 - 4.24 |
8,858,585 |
2,600,000 |
4,182,092 |
|
|
03-05-2022 |
AH |
4:00 PM ET (May 3) |
RIGL |
Rigel Pharmaceuticals |
421.00 |
-0.16 |
-0.12 |
0.00 |
Rigel Pharmaceuticals GAAP EPS of -$0.16 misses by $0.02, revenue of $16.74M misses by $0.8M [5/3/2022 4:12 PM] |
2.65 |
0.17 (6.85%) |
2.49 |
0.01 (0.40%) |
2.19 - 4.62 |
1,631,079 |
1,530,000 |
4,297 |
|
|
01-03-2022 |
AH |
4:00 PM ET (Mar 1) |
RIGL |
Rigel Pharmaceuticals, Inc. |
432.65 |
-0.13 |
-0.13 |
-0.11 |
Rigel Pharmaceuticals GAAP EPS of -$0.13 in-line, revenue of $20.41M misses by $0.79M [3/1/2022 4:31 PM] |
3.02 |
0.51 (20.12%) |
2.51 |
0.0 (0.00%) |
2.19 - 4.62 |
3,977,672 |
1,540,000 |
19,290 |
|
|
02-11-2021 |
AH |
4:00 PM ET (Nov 2) |
RIGL |
Rigel Pharmaceuticals, Inc. |
563.81 |
-0.12 |
-0.10 |
-0.08 |
Rigel Pharmaceuticals EPS beats by $0.14, misses on revenue [11/2/2021 4:05 PM] |
3.45 |
-0.11 (-3.22%) |
3.22 |
-0.35 (-9.80%) |
2.46 - 5.50 |
3,482,752 |
1,020,000 |
153,087 |
|
|
03-08-2021 |
AH |
4:00 PM ET (Aug 3) |
RIGL |
Rigel Pharmaceuticals, Inc. |
680.66 |
-0.08 |
-0.11 |
-0.10 |
Rigel Pharmaceuticals EPS beats by $0.04, beats on revenue [8/3/2021 4:07 PM] |
3.73 |
-0.05 (-1.32%) |
3.73 |
0.0 (0.00%) |
2.14 - 5.50 |
2,323,272 |
1,240,000 |
12,287 |
|
|
05-05-2021 |
AH |
4:00 PM ET (May 5) |
RIGL |
Rigel Pharmaceuticals, Inc. |
632.85 |
0.22 |
0.01 |
0.13 |
Rigel Pharmaceuticals EPS beats by $0.26, beats on revenue [5/5/2021 4:05 PM] |
3.26 |
-0.21 (-6.05%) |
3.26 |
0.0 (0.00%) |
1.70 - 5.50 |
3,256,088 |
2,000,000 |
35,669 |
|
|
02-03-2021 |
AH |
4:00 PM ET (Mar 2) |
RIGL |
Rigel Pharmaceuticals, Inc. |
701.27 |
-0.11 |
-0.10 |
-0.10 |
Rigel Pharmaceuticals EPS in-line, beats on revenue [3/2/2021 4:03 PM] |
3.85 |
-0.46 (-10.57%) |
4.25 |
-0.05 (-1.28%) |
1.23 - 5.50 |
4,501,142 |
6,746,006 |
17,390 |
|
|
05-11-2020 |
AH |
4:00 PM ET (Nov 5) |
RIGL |
Rigel Pharmaceuticals, Inc. |
430.77 |
-0.08 |
-0.12 |
-0.07 |
Rigel Pharmaceuticals EPS beats by $0.04, beats on revenue [11/5/2020 4:06 PM] |
2.61 |
-0.13 (-4.74%) |
2.50 |
-0.24 (-8.76%) |
1.23 - 5.24 |
2,978,718 |
2,392,024 |
26,785 |
|
|
04-08-2020 |
AH |
4:00 PM ET (Aug 4) |
RIGL |
Rigel Pharmaceuticals, Inc. |
387.71 |
-0.10 |
-0.13 |
-0.12 |
Rigel Pharmaceuticals EPS beats by $0.04, beats on revenue [8/4/2020 4:02 PM] |
2.51 |
0.05 (2.03%) |
2.90 |
0.44 (17.89%) |
1.23 - 5.24 |
6,491,518 |
4,629,404 |
333,397 |
|
|
05-05-2020 |
AH |
4:00 PM ET (May 5) |
RIGL |
Rigel Pharmaceuticals, Inc. |
288.25 |
0.13 |
0.13 |
-0.11 |
Rigel Pharmaceuticals EPS in-line, misses on revenue [5/5/2020 4:06 PM] |
1.96 |
0.11 (5.95%) |
0.0 |
0.0 (0.00%) |
1.23 - 3.10 |
2,405,506 |
2,328,339 |
0 |
|
|